Skip to main content

Advertisement

Table 1 Clinical and laboratory data in subject groups

From: Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects

Parameter CTL HYPER HYPO ANOVA
N 30 46 23  
Gender (M/F) 10/20 13/33 5/18 ns
Age (years) 41.7 ± 2.0 34.9 ± 1.6* 39.4 ± 2.5 0.029
BMI (kg/m2) 22.0 ± 0.4 21.2 ± 0.4††† 24.2 ± 0.61* 0.0003
Glucose (mmol/L) 4.88 ± 0.11 5.47 ± 0.07*** 5.08 ± 0.12 <0.0001
Insulin (pmol/L) 34.0 ± 5.5 60.8 ± 4.9*** 33.8 ± 2.8†† <0.0001
HOMA-IR 1.10 ± 0.20 1.86 ± 0.16** 1.02 ± 0.11†† 0.0004
FT4 (pmol/L) 17.4 ± 0.4 64.5 ± 8.4*** 9.1 ± 0.6*††† <0.0001
FT3 (pmol/L) 5.7 ± 0.1 13.3 ± 1.2*** 3.2 ± 0.2**††† <0.0001
TSH (mU/L) 2.1 ± 0.1 0.03 ± 0.02*** 69.5 ± 21.1**††† <0.0001
  1. Results are expressed as average ± SEM for the groups indicated as control (CTL), hyperthyroid (HYPER) and hypothyroid (HYPO) where N = number of subjects per group. Significance was calculated by ANOVA with Bonferroni post-hoc test. Differences vs. control (CTL) group are indicated as *P < 0.05,**P < 0.01,***P < 0.001; and differences for hyperthyroid vs. hypothyroid as p < 0.05, ††p < 0.01, †††p < 0.001, ns = not significant.